Literature DB >> 18633688

Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?

Stefano Ballestri, Amedeo Lonardo, Luisa Losi, Elisa Pellegrini, Marco Bertolotti, Paola Loria.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18633688     DOI： 10.1007/s11739-008-0178-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  10 in total

1.  Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia.

Authors:  Raaj R Sankatsing; Sigrid W Fouchier; Stefan de Haan; Barbara A Hutten; Eric de Groot; John J P Kastelein; Erik S G Stroes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-07-07       Impact factor: 8.311

Review 2.  Clinical features and natural history of nonalcoholic steatosis syndromes.

Authors:  Y Falck-Ytter; Z M Younossi; G Marchesini; A J McCullough
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

3.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

4.  Hepatic steatosis and insulin resistance: does etiology make a difference?

Authors:  Amedeo Lonardo; Silvia Lombardini; Federica Scaglioni; Lucia Carulli; Matteo Ricchi; Dorval Ganazzi; Luigi Elio Adinolfi; Giuseppe Ruggiero; Nicola Carulli; Paola Loria
Journal:  J Hepatol       Date:  2005-07-12       Impact factor: 25.083

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 6.  Drug-induced liver diseases.

Authors:  D Larrey
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

Review 7.  Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Authors:  Geoffrey C Farrell; Claire Z Larter
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

8.  Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B.

Authors:  P Tarugi; A Lonardo; G Ballarini; A Grisendi; M Pulvirenti; A Bagni; S Calandra
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

Review 9.  The wide spectrum of steatohepatitis: a report of four cases and a review of the literature.

Authors:  Amedeo Lonardo; Alberto Bagni; Patrizia Tarugi; Paola Loria
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 2.566

Review 10.  Molecular diagnosis of hypobetalipoproteinemia: an ENID review.

Authors:  Patrizia Tarugi; Maurizio Averna; Enza Di Leo; Angelo B Cefalù; Davide Noto; Lucia Magnolo; Luigi Cattin; Stefano Bertolini; Sebastiano Calandra
Journal:  Atherosclerosis       Date:  2007-06-14       Impact factor: 5.162
  10 in total
  2 in total

Review 1.  Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management.

Authors:  Jooho Lee; Robert A Hegele
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

2.  Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia.

Authors:  Maartje E Visser; Fatima Akdim; Diane L Tribble; Aart J Nederveen; T Jesse Kwoh; John J P Kastelein; Mieke D Trip; Erik S G Stroes
Journal:  J Lipid Res       Date:  2009-12-14       Impact factor: 5.922
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.